InvestorsHub Logo
Post# of 175120
Next 10
Followers 7
Posts 926
Boards Moderated 1
Alias Born 06/17/2019

Re: None

Friday, 03/31/2023 7:50:13 AM

Friday, March 31, 2023 7:50:13 AM

Post# of 175120
https://www.hopkinsmedicine.org/news/articles/radiopharmaceutical-therapy-in-veterinary-patients

Not only do they talk about Isopet/Radiogel in here, but if you keep reading they talk about a new radiopharmaceutical therapy that uses tin-117m which is for osteoarthritis in dogs. Synovetin OA, from Exubrion Therapeutics uses tin-117m and recently has announced a joint abstract with Vivos Inc.

https://www.radiogel.com/2023/01/10/exubrion-therapeutics-and-vivos-inc-collaborate-on-joint-abstract/

Nigel is Exubrion Therapeutics’ Chief Operations Officer and is also the Vivos Inc Chief Science Advisor. The two companies cooperate since they are in totally different therapy markets. The CEOs of both companies decided that it is in their best interest to promote the benefits of precision radionuclide therapy.



I have a strong feeling there's a lot more going on behind the scenes that hasn't been publicly talked about. Sometimes silence is painful, but sometimes it's the best thing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News